Resources
Covid-19 Resources

Covid-19 Resources

In December 2019, a new strain of human coronavirus was detected – initially called 2019-nCoV – in few patients with viral pneumonia in Wuhan, China. The EAACI community is united in disseminating new research and knowledge on the COVID-19 pandemic. Find some of the most useful related content here to better serve you and your patients. More resources on COVID-19 will be added as they are released by our community of experts.

All Covid-19 Resources

Filter

What are you looking for?

Category
- Aerobiology and pollution
- Allergen immunotherapy
- AllergoOncology
- Allergy asthma and a sport
- Allergy diagnosis
- Allied health and primary care
- Anaphylaxis
- Asthma
- Basic immunology
- Biologicals
- Comparative veterinary allergology
- COVID19
- Dermatology
- Drug allergy
- ENT
- Environmental allergy and climate change
- Eosinophilic esophagitis
- Epidemiology
- Epithelial cell biology
- Food allergy
- Food Allergy and Anaphylaxis
- Genomics and proteomics
- Immune deficiencies and autoimmunity
- Immunomodulation and nutrition
- Infections
- Mastocytosis and mast cells
- Microbiome
- Occupational allergy
- Ocular allergy
- OMIC Technologies in Allergy Research
- Pediatrics
- Prevention
- Systems medicine
- T2 Diseases
Year
- 2013
- 2014
- 2015
- 2016
- 2017
- 2019
- 2020
- 2021
- 2022
Keywords
- nasal polyps…)
- sinusitis
- vaccines and mechanisms
- “omics” and systems biology
- “omics” and systems biology
- (reverse) zoonosis
- AAMP
- Abdominal pain
- ACE2
- Acoustic rhinometry
- acute respiratory tract infection
- Adherence
- Adjuvant
- Adjuvants
- adolescent
- Adolescents
- Adrenaline
- Adrenaline auto-injector
- adults
- adverse drug reaction
- advocacy
- aerd
- aerobiology
- Air pollutant
- Air pollution
- Airborne enzyme
- AIT
- Algorithm
- allergen
- allergen immunotherapy
- allergen immunotherapy (AIT)
- Allergen labelling
- Allergen sequence database
- Allergen-free foods
- allergen-immuntherapie
- allergens and epitopes
- Allergens and epitopes
- allergic asthma
- Allergic conjunctivitis (AC)
- Allergic contact dermatitis
- allergic disease
- allergic diseases
- allergic rhinitis
- Allergic rhinitis (AR)
- allergicdiseases
- allergicrhinitis
- allergie
- allergy
- Allergy diagnosis
- allergy diagnosis
- allergy epidemiology
- allergy hypersensititvy
- allergy management
- Allergy risk
- allergy test
- allergy treament
- allergy treatment
- Allergy treatment
- allergy/hypersensitivity
- ALR
- Alternaria
- altitude
- Anaphylaxis
- Angioedema
- angiotensin-convertingenzyme2
- angiotensin-convertingenzymeII
- Animal models
- Anosmi
- antibiotics
- Antibodies
- antibody
- antibody-dependentenhancement
- antibodydynamics
- Antiepileptic drugs hypersensitivity
- Antolimab
- Api m 10
- APOE
- ARPC1B
- Artificial intelligence
- Asthma
- asthma control
- asthma exacerbations
- Asthma treatment
- Asthma treatment
- asymptomatic
- Atopic dermatitis
- atopic dermatitis
- Atopic dermatitis (AD)
- Atopic deseases
- Atopic eczema
- Atopic eosinophilic asthma
- Autoallergen
- Autoimmunity
- Autoinflammation
- Avapritinib
- Azelastine fluticasone
- B cells
- bacterial lysates
- Barrier
- Basic immunology
- Basic mechanisms
- basic mechanisms
- Basophil
- Basophil activation test
- basophil activation test (BAT)
- Bathing
- Bcells
- Beijing
- Benralizumab
- Bet v 1
- beta-lactam
- beta-lactam allergy
- Big data
- bigdata
- Bioinformatics
- Biological detergents
- biologicals
- Biologics
- biologika
- biomarker
- Biomarkers
- biosafety
- Biotin
- Birch
- Birch pollen
- blood
- BNT162b2
- Bovine milk
- Breast milk
- Breastfeeding
- Breg cells
- bronchial allergen challenge
- bronchial asthma
- Bronchiolitis
- Bronchoconstriction
- BTK
- cabbage
- cancer
- cannabis allergy
- Cellular test
- challenge tests
- Challenge tests
- chemotherapy
- child
- Childhood allergies
- childhoodvaccination
- children
- china
- chlorination by-products
- Chronic respiratory
- Chronic rhinosinusitis
- Chronic rhinosinusitis with nasal polyposis (CRSwNP)
- chronic spontaneous urticaria
- Chronic spontaneous urticaria (CSU)
- chronic urticaria
- chronicrhinosinusitis
- chronicrhinosinusitiswithnasalpolyps
- chronicurticaria
- chronis rhinosinusitis
- climate
- Clinical aspects
- clinical endotypes
- Clinical immunology
- Clinical immunology Food allergy
- Clinical practice
- clinical relevance
- clinicalimmunology
- Cluster analysis
- cofactors
- Collegen-binding receptor
- common cold
- community
- companion animals and pets
- Company Sponsored Symposia
- Component resolved diagnosis (CRD)
- Conjunctiva
- Consensus
- consensus document
- contact dermatitis
- Contact urticaria
- containment
- coronavirus
- coronavirusdisease2019
- Cost-effectiveness
- cough
- COVID
- COVID-19
- COVID-19 lockdown
- COVID-19 vaccine
- COVID-19[SupplementaryConcept]
- COVID-19diagnostictesting[SupplementaryConcept]
- COVID-19vaccines
- COVID‐19
- COVID19
- Cow's milk
- Cow's milk allergy
- CRISPR
- criticalillness
- Cross-reactive molecules
- Cross-reactivity
- CRSwNP
- Cutaneous manifestation
- cyclosporine
- cytokine
- DAMP
- danger signals
- Danger signs
- Deep learning
- Dermatology
- desensitization
- dexamethasone
- DGAKI
- diagnosis
- diet
- Differential diagnosis
- disease (CRD)
- disease burden
- disease transmission
- disinfection by-products
- DNase
- drug allergy
- Drug allergy
- Drug allergy diagnosis
- Drug desensitisation
- Drug hypersensitivity
- drug provocation test
- drug provocation test (dpt)
- Drug provocation tests
- dupilumab
- Dysbiosis
- E-cigarette
- eaaci hybrid congress 2022
- ECDA
- Education
- efficacy
- Egg allergy
- eHealth
- Eldery
- Elimination diet
- Emollient
- Endotype
- Endotypes
- ENT
- ENT (rhinitis
- environment
- Environment and hygiene hypothesis
- Environmental exposure chamber (EEC)
- environmentalhealth
- Enzyme-LinkedImmunosorbentAssay[Mesh]
- Eosinophilic granulomatosis with polyangiitis (EGPA)
- Eosinophils
- Epicutaneous
- Epicutaneous immunotherapy
- Epidemiology
- Epithelial barrier
- Epithelial barrier hypothesis
- epithelialcell
- Epithelium
- Epitome
- Epitope specific IgA
- ERS/EAACI
- EU
- exacerbations
- Exercise induced anaphylaxis (EIAn)
- Exercise induced asthma
- experimental models
- exposome
- fermentedvegetable
- Flow cytometric
- Flow cytometry
- flow-diagram
- flowcytometry
- food
- food allergy
- Food allergy
- Food aversion
- Food processing
- Food-dependent exercise-induced anaphilaxis (FDEIAn)
- Food-induced anaphylaxis (FIA)
- Fungi
- Gene expression
- Genetics
- Genome-wide association study (GWAS)
- global atlas
- glycans
- grade
- Grant application
- guideline
- Guidelines
- Gut microbiota
- health economics
- Helicobacter pylori
- Helminth infection
- hereditary angioedema
- Hereditary angioedema (HAE)
- Histamine
- Histamine intolerance
- Hologenome
- House dust mite
- House dust mite (HDM)
- house dust mites
- housedust mites
- Human bronchial smooth muscle cells (BMSC)
- hygiene
- Hypereosinophilic syndrome (HES)
- hyperinflammation
- hypersensitivity
- hypersensitivity reactions
- IgE
- IL-37b
- immediate reactions
- Immune amnesia
- Immune deficiencies
- Immune health
- immune response
- Immune tolerance
- immunecomplex
- immuneresponse
- Immunization
- immunodeficiencies
- immunoglobulinM
- immunoglobulins
- Immunologic tests
- Immunologic tests
- Immunomodulators
- immunotherapy
- Immunotherapy and tolerance induction
- Immunotherapy clinical
- Immunotherapy vaccines and mechanisms
- Immunotherapy vaccines and mechanisms
- implementationscience
- In vitro assays
- Inborn errors of immunity (IEI)
- Infections
- inferiorturbinate
- Inflammasome
- Inflammation
- Inflammatory bowel disease (IBD)
- inflammatoryendotype
- innate immunity
- Innate immunity
- Innate lymphoid cells and NK cells
- innateimmunity
- Innovation
- integrated care
- Integrines
- interferon
- Interferons
- Interleukins
- international consensus
- intradermal test
- Iodinated contrast media
- italy
- Kawasakisyndrome
- kimchi
- Lactobacillus
- learning methods
- ligelizumab
- lipid transfer protein
- Lipid transfer protein (LTP)
- Local allergic rhinitis
- Lolium Perenne
- long-term immunity
- Long-term prophylaxis
- LTP
- LTRA
- Lung diseases other than asthma and COPD
- lung function
- lung function test
- Lung function tests
- lymphocyte transformation test (LTT)
- Lymphocytes
- Machine learning
- Macrophages
- Malignant
- management
- marketing authorization
- Masitinib
- Mast cells
- Mast cells
- Mast cells Dermatology
- mastocytosis
- Mastocytosis scale (QLMS)
- mechanisms
- memory B cells
- Mepolizumab
- Metabolite
- metabolites
- Metabolomics
- Metalloproteinase 9
- mHealth
- Microbiome
- microbiota
- microRNA
- MicroRNA (miRNA)
- Mobile health (mHealth)
- Moisturisers
- molecular allergology
- Molecular phenotypes
- molecularinteractionassay
- Molecules
- monoclonal Abs
- MOOC
- MRGPRX2
- mRNA
- mRNA vaccines
- multi-disciplinary management
- Multiple myeloma
- multisysteminflammatorysyndrome
- mumps‐measles‐rubella
- myeloperoxidase
- neonates
- Neuroimmunology
- Neuronal control
- Neutralizing[Mesh]
- neutralizingantibody
- neutrophil extracellular traps (NETs)
- neutrophilextra-cellulartraps(NETs)
- neutrophils
- newborns
- Next generation
- NLR
- non-immediate reactions
- non-specialist care
- non-steroidal anti-inflammatory drugs (NSAID)
- noninvasive diagnosis
- Novel mechanisms
- NSAID
- nsaid-exacerbated respiratoy disease (NERD)
- nutrients
- Nutrition
- Obesity
- Occupational asthma
- occupational exposure
- Ocular allergy
- Olfactory disturbance
- Olink
- omalizumab
- omic
- One Health
- OneHealth
- Oral allergy syndrome (OAS)
- oral corticosteroids
- Oral immunotherapy
- outbreak
- Outcome measures
- Paediatrics
- PAMP
- Panallergen
- pandemic
- Particular matter (PM)
- Patch test
- Patch tests
- patient reported outcome
- patient-centered care
- peak expiratory flow
- Peanut
- Peanut allergy
- pediatric
- pediatric aspects
- pediatrics
- Peptide immunotherapy
- perioperative allergy
- Personalized medicine
- pharmacoeconomics
- Pharmacology and pharmacogenomics
- Phenotype
- phenotypes
- Pine nut allergy
- PIPEline
- Placebo effect
- Plane tree
- Platanus hybrida
- Pneumology
- pneumonia
- Polish Allergology Society
- Pollen
- Pollen food syndrome
- Pollen forecast
- Pollen monitoring
- pollution
- PRACTALL
- Precision medicine
- precision medicine
- prediction
- Prediction model
- Pregnancy
- Prematurity
- preschool
- Prevention
- primary care
- Probiotic
- probiotics
- proresolvinglipids
- protection
- protectiveantibodies
- Proteotomics
- Proton pump inhibitor
- Psoriasis
- psychological effects
- pulmonary rehabilitation
- Quality-of-life
- qualitycriteria
- Questionnaire
- race
- Ragweed
- randomized controlled trial
- Rapid drug desensitization
- Real life
- real-world evidence
- Recipe
- recreational exposure
- RED-ZONE
- regulation
- Regulatory aspects
- regulatory authorities
- RELEVANT
- Remodelling
- respiratory allergy
- Respiratory infections
- Rhinitis
- Rhinitis Monitoring
- rhinoconjuctivitis
- Rhinoconjunctivitis
- Rhinosinusitis (RS)
- Rhinovirus
- risk assessment
- risk factors
- riskfactors
- RLR
- safety
- SANI
- SARS-CoV
- SARS-CoV-2
- SARS-CoV-2 vaccine
- SARS‐CoV‐2
- Satellite Symposia
- SCARs (severe cutaneous adverse drug reactions)
- SCIT
- self-care
- self‐management
- sensitization
- Sepsis
- sequencing (NGS)
- severe allergic reactions
- severe asthma
- Severe cutaneous adverse drug reactions (SCARs)
- SevereAcuteRespiratorySyndromeCoronavirus2[SupplementaryConcept]
- severeallergicreactions
- severity
- sIgG
- Single nucleotide polymorphisms (SNPs)
- sinus
- Skin
- skin allergy
- Skin barrier
- skin diseases
- skin test
- Skincare
- sleep pattern
- SLIT
- smell
- SoMe
- Spirometry
- Sports
- sputuminduction
- Stallergenes Greer
- standardization
- Stevens-Johnson syndrome (SJS)
- Stratification
- subcutaneous immunotherapy
- Sublingual
- sublingual immunotherapy
- sulforaphane
- Sulfur mustard Stem cells
- supplementation
- survey
- Symptom scale
- Symptom score
- systematic review
- Systemic mastocytosis (SM)
- T cells
- T cells
- t2 diseases
- Tcells
- Terriers
- Tezepelumab
- Th2 cell
- Th2 sensitization
- Thunderstorm asthma
- TLR
- TMPRSS2
- tolerance
- Trained immunity
- trainedimmunity
- Transcriptome
- Transcriptomics
- transition
- Transition process
- translationalresearch
- transmissionofdisease
- treatment
- Tree-nut allergy
- Tryptase
- UCARE
- umfrage
- unmet needs
- Urban green spaces
- Urban particulate matter
- Urticaria
- urticaria diagnosis
- urticaria treatment
- Vaccination
- vaccine
- Vaccines
- Vaping
- Venom and insect allergy
- venom immunotherapy
- Viral reactivation
- Virtual care
- Virus
- WAO
- wheezing
- white paper
- Xlinkedagammaglobulinemia
- young
- young adults
Author
- Adamiec, A.
- Adcock, I.
- Agache, I.
- Aggelides, X.
- Akdis, C.A.
- Akdis, M.
- Akin, C.
- Allegri, P.
- Alvarez-Cuesta, E
- Alvarez-Perea, A.
- Alvaro-Lozano, M.
- Alviani, C.
- Ambrożej, D.
- Angier, E.
- Anna Pastorello, E.
- Annesi-Maesano, I.
- Antje Faber, M.
- Antolin-Amerigo, D.
- Antunes, C.
- Apoil, P.
- Arasi, S.
- Arcolaci, A.
- Arkhipova, S.
- Arnold, A.
- Asero, R.
- Atanaskovic-Markovic, M.
- Ayane, A.
- Bachert, C.
- Baerenfaller, K.
- Ballmer-Weber, B.K.
- Barbaud, A.
- Barber, D.
- Bartel, S
- Bartra, J.
- Baumann, R
- Bavbek, S.
- Bazan-Socha, S.
- Beck, L.
- Bedbrook, A.
- Bégin, P.
- Beken, B.
- Bergmann, C.
- Bernard, A.
- Bernstein, D.
- Bernstein, J.
- Besednjak-Kocijancic, L.
- Beyer, K.
- Bikov, A.
- Bindslev-Jensen, C.
- Birrell, F.
- Bisyuk, y.
- Bjermer, L.
- Blanca-Lopez, N.
- Blumchen, K.
- Boccabella, C.
- Bohle, B.
- Böhm, I.
- Bonini, M.
- Bosnic-Anticevich, S.
- Bousquet, J.
- Boyce, J.
- Boyle, R.
- Bozek, A
- Bozkurt, B.
- Branicka, O.
- Braun, A.
- Braunstahl, G.
- Brignole-Baudouin, F.
- Brockow, K.
- Brough, H.A.
- Brucker, H.
- Burks, W.
- Caballero, M.
- Cabanillas, B.
- Cabrera, M.
- Calder, V.
- Calderon, M
- Campbell, D.
- Canonica, G.W.
- Caruso, C.
- Castells, M.
- Caubet, J-C.
- Caubet, J.-C.
- Cavaleiro Rufo, J.
- Cecchi, L.
- Chaker, A.
- Chan, E.
- Chawes, B.
- Chivato, T.
- Cianferoni, A.
- Clark, A.
- Clark, E.
- Clini, E.
- Cogo, A.
- Comberiati, P.
- Cornejo-Garcia, JA
- Correia-de-Sousa, J.
- Corren, J.
- Corrigan, C.
- Coutinho, C.
- Couto, M.
- Craig, T.
- Cullinan, P.
- Cunha, I.
- Custovic, A.
- D'Amato, G.
- Davidescu, L.
- de Blay, F.
- de Jong, N.
- de las Vecillas, L.
- de Silva, D.
- de Swart, R.
- de Waard-van der Spek, F.
- del Giacco, S.
- Delgado, L.
- Demoly, P
- Descamps, V.
- Deshpande, D.
- di Bona, D.
- Diamant, Z.
- Diaz Perales, A.
- Diwakar, L.
- Doğru, M.
- Domínguez Andrés, J.
- Doña, I.
- Dramburg, S.
- Drijver-Messelink, MT
- du Toit, G.
- Duca, B.
- DunnGalvin, A.
- Durham, S.
- Ebo, D.G.
- Eguiluz-Gracia, I.
- Eguiluz, I.
- Eiwegger, T.
- Elenius, V
- Emson, C.
- Erkekol, F.
- Eyerich, K.
- Faber, M.A.
- Farkas, H.
- Fauquert, J.
- Feketea, G.
- Fernández Santamaría, R.
- Fernández-Rivas, M.
- Fieten, KB
- Figueras Alsius, M
- Firinu, D.
- Flokstra – de Blok, BMJ
- Flood, B.
- Florsheim, E.
- Fokkens, W.
- Forastiere, F.
- Fu, W.
- Garriga-Baraut, T.
- Garvey, LH
- Gelincik, A.
- Geng, B.
- Genuneit, J.
- Gern, J.
- Gerth van Wijk, R.
- Gevaert, P.
- Giménez-Arnau, A.
- Giovannini, M.
- Golding, M.
- Gomes, E.R.
- Gomez, F.
- González Díaz, S
- Goodman, R.
- Gore, C.
- Gowland, M.
- Greenhawt, M.
- Gunawardana, N.
- Gutermuth, J.
- Guttman, E.
- Halken, S.
- Hamilton, J.
- Hartmann, K.
- Heffler, E.
- Heldner, A.
- Hellings P.
- Hermuth-Kleinschmidt, K.
- Herth, F.
- Hilger, C.
- Hoffmann-Sommergruber, K.
- Hoffmann, H-J.
- Holgate, S.
- Holmdahl, I.
- Horvath, I.
- Howarth, P.
- Hox, V.
- Huang, Y
- Jackson, D.
- Jacobsen, L.
- Janda, J.
- Janson, C.
- Jeebhay, M.
- Jeimy, S.
- Jensen, B.
- Jiménez-Saiz, R.
- Johnston, S.
- Jones, A.
- Jutel, M.
- K Chu, D.
- Kalayci, O.
- Kang, M.
- Kappen, J.
- Kase Tanno, L.
- Kelleher, M.
- Khaitov, M.
- Khaleva, E.
- Kheradmand, F.
- Kidon, M.
- Kılıç, A.
- Kleine-Tebbe, J.
- Kleuskens, M.
- Klimek, L.
- Knibb, R.
- Knol, E.
- Kocatürk, E.
- Köhler, V.
- Konstantinopoulos, A.P.
- Korath, ADJ
- Korn, S.
- Kortekaas Krohn, I.
- Kosowska, A.
- Kothalawala, D.
- Kozlik, P.
- Kündig, T.
- Kuyucu, S.
- Kuziemski, K.
- Lack, G.
- Lang, D.
- Larché, M.
- Lau, S.
- Lee, Y.
- Leonardi, A.
- Luengo, O.
- Macchia, L.
- Madrigal-Burgaleta, R.
- Mahler, V.
- Maleki, S.
- Malmberg, PL.
- Marrs, T.
- Martins, C.
- Maspero, J.
- Mathioudakis, A.
- Matricardi, P
- Matucci, A.
- Maurer, M.
- Mayorga, C.
- McSorley, H.
- Meyer, R.
- Mikkelsen, A.
- Mockenhaupt, M.
- Moloudizargari, M.
- Montimer, K.
- Mori, F.
- Mortz, C.G.
- Mösges, R.
- Mukherjee, M.
- Muraro, A
- Myszkowska, D.
- Nadeau, K.C.
- Nasser, S.
- Nwaru, B.
- O’Mahony, L.
- Ogese, M.
- Ogg, G.
- Ollert, M.
- Ong, P.Y.
- Pagani, M.
- Pali-Schöll, I
- Palomares, O.
- Paoletti, G.
- Papadopoulos, N.
- Paplinska-Goryca, M.
- Park, H.
- Pastorello, E.A.
- Pavord, I.
- Peden, D.
- Pepys, J.
- Pérez de Llano, L.
- Perkin, M.
- Permaul, P.
- Peters, A.
- Pfaar, O.
- Pinnock, H.
- Pite, H.
- Pitsios, C.
- Poli, A.
- Popescu, F.
- Portelli, M.
- Qazi, K.
- Rabin, R.L.
- Radzikowska, U.
- Reese, I.
- Reginald, K.
- Renz, H.
- Reynolds, N.
- Ricci, C.
- Riggioni, C.
- Ring, J.
- Roberts, G
- Roberts, G.
- Rodrigo-Muñoz, J.
- Rossi, A.
- Rostaher, A.
- Rovati, GE
- Rudenko, M.
- Rukhadze, M.
- Rustemeyer, T.
- Ryan, D.
- Sabato, V.
- Sabouraud, D.
- Sadeghi, S.
- Salapatek, A.
- Sanchez-Garcia, S.
- Sandoval-Ruballos, M.
- Santos, A.
- Scadding, G
- Scala, E.
- Scheib, N.
- Scherrer, K.
- Schmid, B.
- Schwarze, J.
- Sediva, A.
- Semernik, O.
- Shamji, M.H.
- Skypala, I.J.
- Smolinska, S.
- Sokolowska, M.
- Song, K.
- Soyer, O.
- Spergel, J.
- Spolak-Bobryk, N.
- Stevens, W.
- Straumann, A.
- Sublett, J.
- Suojalehto, H.
- Suprun, M.
- Swanson, W.S.
- Swoboda, I.
- Szajewska, H.
- Szymanski, L.
- Tan, B.
- Thibaudon, M.
- Thien, F.
- Thirumala Krishna, M.
- Till, S.J.
- Timmermans, F.
- Tonia, T.
- Torres, M.J.
- Torun, E.
- Traidl-Hoffmann, C.
- Tramper-Stranders, G.
- Trautmann, A.
- Troy, N.
- Tsabouri, S.
- Tsilochristou, O.
- Untersmayr, E.
- Van Bilsen, J.
- Van Cuilenborg, V.
- van den Berge, M.
- van Neerven, R.
- van Ree, R.
- Van Weissenbruch, R.
- Vandenplas, Y.
- Vassilopoulou, E.
- Vazquez-Ortiz, M.
- Vega Castro, A.
- Venter, C.
- Verhasselt, V.
- Vieths, S.
- Vlieg- Boerstra, B.
- von Mutius, E.
- Vultaggio, A.
- Walter, J.
- Wardzynska, A.
- Warner, A.
- Weidner, J.
- Werfel, T.
- Wiehn, E.
- Wong, C.
- Worm, M.
- Worm, M.
- Zhang, L.
- Zieglmayer, P.
- Zissler, UM
- Zuberbier, T.

COVID-19 Resource 2022

Cutaneous manifestations related to coronavirus disease 2019 (COVID-19): A prospective study from China and Italy

Read about this COVID-19 Resource
COVID-19 Resource 2022

Position statement of expert panel of the Polish Allergology Society (PTA) on the management of patients with bronchial asthma and allergic diseases during the SARS-CoV-2 pandemic

Read about this COVID-19 Resource
COVID-19 Resource 2022

A Global Effort to Define the Human Genetics of Protective Immunity to SARS-CoV-2 Infection

Read about this COVID-19 Resource
COVID-19 Resource 2022

Angiotensin‐converting enzyme II expression and its implication in the association between COVID‐19 and allergic rhinitis

Read about this COVID-19 Resource
COVID-19 Resource 2022

Dexamethasone, pro‐resolving lipid mediators and resolution of inflammation in COVID‐19

Read about this COVID-19 Resource
COVID-19 Resource 2022

The role of circulating eosinophils on COVID‐19 mortality varies by race/ethnicity

Read about this COVID-19 Resource
COVID-19 Resource 2022

Elastase and Exacerbation of Neutrophil Innate Immunity are Involved in Multi‐Visceral Manifestations of COVID‐19

Read about this COVID-19 Resource
COVID-19 Resource 2021

Skin tests in urticaria/angioedema and flushing to Pfizer‐BioNTech SARS‐CoV‐2 vaccine: limits of intradermal testing

Read about this COVID-19 Resource
COVID-19 Resource 2021

Vaccines and allergic reactions: the past, the current COVID‐19 pandemic, and future perspectives

Read about this COVID-19 Resource
COVID-19 Resource 2021

Real‐life impact of COVID‐19 pandemic lockdown on the management of pediatric and adult asthma: a survey by the EAACI Asthma Section

Read about this COVID-19 Resource
COVID-19 Resource 2021

Detection of SARS‐CoV‐2 Specific Memory B cells to Delineate Long‐Term COVID‐19 Immunity

Read about this COVID-19 Resource
COVID-19 Resource 2021

Pros and Cons for the role of air pollution on COVID-19 Development

Read about this COVID-19 Resource
COVID-19 Resource 2021

Differentiation of COVID-19 signs and symptoms from allergic rhinitis and common cold – an ARIA- EAACI – GA2LEN consensus

Read about this COVID-19 Resource
COVID-19 Resource 2021

Allergenic components of the mRNA‐1273 vaccine for COVID‐19: possible involvement of polyethylene glycol and IgG‐mediated complement activation

Read about this COVID-19 Resource
COVID-19 Resource 2021

COVID-19 Pandemic and allergen immunotherapy – an EAACI survey

Read about this COVID-19 Resource
COVID-19 Resource 2021

Impact of anxiety, stress and depression related to COVID-19 pandemic on the course of hereditary angioedema with C1 inhibitor deficiency

Read about this COVID-19 Resource
COVID-19 Resource 2021

Childhood asthma outcomes during the COVID-19 pandemic: Findings from the PeARL multi-national cohort

Read about this COVID-19 Resource
COVID-19 Resource 2021

Management of patients with atopic dermatitis undergoing systemic therapy during COVID‐19 pandemic in Italy: data from the DA‐COVID‐19 registry

Read about this COVID-19 Resource
COVID-19 Resource 2021

Enzymatic activity of ACE2 regulates type 2 airway inflammation in mice

Read about this COVID-19 Resource
COVID-19 Resource 2021

EAACI statement on the diagnosis, management and prevention of severe allergic reactions to COVID‐19 vaccines

Read about this COVID-19 Resource
COVID-19 Resource 2021

Association of endopeptidases, involved in SARS‐CoV‐2 infection, with microbial aggravation in sputum of severe asthma

Read about this COVID-19 Resource
COVID-19 Resource 2020

Genetic Predisposition to allergic diseases is inversely associated to risk of COVID-19

Read about this COVID-19 Resource
COVID-19 Resource 2020

ARIA‐EAACI statement on severe allergic reactions to COVID‐19 vaccines – an EAACI‐ARIA position paper

Read about this COVID-19 Resource
COVID-19 Resource 2020

SARS-COV-2 Candidate vaccines – composition, mechanisms of action and stages of clinical development

Read about this COVID-19 Resource
COVID-19 Resource 2020

Allergic reactions to the first COVID‐19 vaccine: a potential role of polyethylene glycol?

Read about this COVID-19 Resource
COVID-19 Resource 2020

Multidisciplinary consensus on sputum induction biosafety during the COVID-19 pandemic

Read about this COVID-19 Resource
COVID-19 Resource 2020

The global impact of the COVID-19 pandemic on the management and course of chronic urticaria

Read about this COVID-19 Resource
COVID-19 Resource 2020

Association between asthma and clinical mortality/morbidity in COVID‐19 patients using clinical epidemiologic data from Korean Disease Control & Prevention

Read about this COVID-19 Resource
COVID-19 Resource 2020

Distinct expression of SARS- CoV-2 receptor ACE2 correlates with endotypes of rhinosinusitis with nasal polyps

Read about this COVID-19 Resource
COVID-19 Resource 2020

Risk factors for severe and critically ill COVID-19 patients: A review

Read about this COVID-19 Resource
COVID-19 Resource 2020

Immunological imprint of COVID-19 on human peripheral blood leukocyte populations

Read about this COVID-19 Resource
COVID-19 Resource 2020

Is there a role for childhood vaccination against COVID-19?

Read about this COVID-19 Resource
COVID-19 Resource 2020

Management of patients with chronic rhinosinusitis during the COVID‐19 pandemic – An EAACI Position Paper

Read about this COVID-19 Resource
COVID-19 Resource 2020

Antibody dynamics to SARS‐CoV‐2 in asymptomatic COVID‐19 infections

Read about this COVID-19 Resource
COVID-19 Resource 2020

Regional differences in ACE2 expression in the sinonasal mucosa of adult Chinese patients with chronic rhinosinusitis

Read about this COVID-19 Resource
COVID-19 Resource 2020

Characterization of asthma and risk factors for delayed SARS‐CoV‐2 clearance in adult COVID‐19 inpatients in Daegu

Read about this COVID-19 Resource
COVID-19 Resource 2020

Accuracy of serological testing for SARS‐CoV‐2 antibodies: first results of a large mixed‐method evaluation study

Read about this COVID-19 Resource
COVID-19 Resource 2020

Small droplet emission in exhaled breath during different breathing manoeuvres: Implications for clinical lung function testing during COVID‐19

Read about this COVID-19 Resource
COVID-19 Resource 2020

Asthma control, self‐management and healthcare access during the COVID‐19 epidemic in Beijing

Read about this COVID-19 Resource
COVID-19 Resource 2020

The younger the milder clinical course of COVID-19 – even in infants?

Read about this COVID-19 Resource
COVID-19 Resource 2020

The potential threat of multisystem inflammatory syndrome in children during the COVID-19 pandemic

Read about this COVID-19 Resource
COVID-19 Resource 2020

Thirty‐six COVID‐19 cases preventively vaccinated with mumps‐measles‐rubella vaccine: all mild course

Read about this COVID-19 Resource
COVID-19 Resource 2020

Atopic status protects from severe complications of COVID‐19

Read about this COVID-19 Resource
COVID-19 Resource 2020

Severe asthma in adults does not significantly affect the outcome of COVID‐19 disease: results from the Italian Severe Asthma Registry

Read about this COVID-19 Resource
COVID-19 Resource 2020

Cabbage and fermented vegetables: from death rate heterogeneity in countries to candidates for mitigation strategies of severe COVID‐19

Read about this COVID-19 Resource
COVID-19 Resource 2020

Shielding against SARS-CoV-2 infections is not justified in children with severe asthma

Read about this COVID-19 Resource
COVID-19 Resource 2020

Cross‐sectional pilot study exploring the feasibility of a rapid SARS‐CoV‐2 immunization test in health and nonhealthcare workers

Read about this COVID-19 Resource
COVID-19 Resource 2020

Delayed virus‐specific antibody responses associate with COVID‐19 mortality

Read about this COVID-19 Resource
COVID-19 Resource 2020

Blood myeloperoxidase‐DNA, a biomarker of early response to SARS‐CoV‐2 infection?

Read about this COVID-19 Resource
COVID-19 Resource 2020

COVID‐19 in Severe Asthma Network in Italy (SANI) patients: Clinical features, impact of comorbidities and treatments

Read about this COVID-19 Resource
COVID-19 Resource 2020

Antibodies in serum of convalescent patients following mild COVID‐19 do not always prevent virus‐receptor binding

Read about this COVID-19 Resource
COVID-19 Resource 2020

Bacillus Calmette‐Guérin vaccination and socioeconomic variables vs COVID‐19 global features: Clearing up a controversial issue

Read about this COVID-19 Resource
COVID-19 Resource 2020

SARS‐CoV‐2 receptor ACE2 protein expression in serum is significantly associated with age

Read about this COVID-19 Resource
COVID-19 Resource 2020

A male infant with COVID-19 in the context of ARPC1B Deficiency

Read about this COVID-19 Resource
COVID-19 Resource 2020

Genome-wide CRISPR screen reveals host genes that regulate SARS-CoV-2 infection

Read about this COVID-19 Resource
COVID-19 Resource 2020

Postnatal SARS‐CoV‐2 Infection and Immunological Reaction: A Prospective Family Cohort Study

Read about this COVID-19 Resource
COVID-19 Resource 2020

First antibody trial launched in COVID-19 patients

Read about this COVID-19 Resource
COVID-19 Resource 2020

African American children are at higher risk for COVID‐19 infection

Read about this COVID-19 Resource
COVID-19 Resource 2020

SARS-CoV-2 receptor ACE2 is an interferon-stimulated gene in human airway epithelial cells and is detected in specific cell subsets across tissues

Read about this COVID-19 Resource
COVID-19 Resource 2020

APOE e4 Genotype Predicts Severe COVID-19 in the UK Biobank Community Cohort

Read about this COVID-19 Resource
COVID-19 Resource 2020

Symptoms and immunoglobulin development in hospital staff exposed to a SARS‐CoV‐2 outbreak

Read about this COVID-19 Resource
COVID-19 Resource 2020

The first, holistic immunological model of COVID‐19: Implications for prevention, diagnosis, and public health measures

Read about this COVID-19 Resource
COVID-19 Resource 2020

Biologics increase the risk of SARS-CoV-2 infection and hospitalization, but not ICU admission and death: real-life data from a large cohort during RED-ZONE declaration

Read about this COVID-19 Resource
COVID-19 Resource 2020

SARS‐CoV‐2 infection in children – Understanding the immune responses and controlling the pandemic

Read about this COVID-19 Resource
COVID-19 Resource 2020

Association of Respiratory Allergy, Asthma and Expression of the SARS-CoV-2 Receptor, ACE2

Read about this COVID-19 Resource
COVID-19 Resource 2020

Successful containment of COVID‐19 outbreak in a large maternity and perinatal center while continuing clinical service

Read about this COVID-19 Resource
COVID-19 Resource 2020

Two X‐linked agammaglobulinemia patients develop pneumonia as COVID‐19 manifestation but recover

Read about this COVID-19 Resource
COVID-19 Resource 2020

Managing childhood allergies and immunodeficiencies during respiratory virus epidemics – the 2020 COVID‐19 pandemic – A statement from the EAACI-Section on Pediatrics

Read about this COVID-19 Resource
COVID-19 Resource 2020

COVID-19: Pandemic Contingency Planning for the Allergy and Immunology Clinic

Read about this COVID-19 Resource
COVID-19 Resource 2020

World Allergy Organization (WAO): Preparing your office for the COVID-19 Pandemic

Read about this COVID-19 Resource
COVID-19 Resource 2020

DGAKI statement on asthma and COVID-19

Read about this COVID-19 Resource

Show more COVID-19 Resources (59)

Covid-19 Resources

All Covid-19 Resources

What are you looking for?

Cutaneous manifestations related to coronavirus disease 2019 (COVID-19): A prospective study from China and Italy

Position statement of expert panel of the Polish Allergology Society (PTA) on the management of patients with bronchial asthma and allergic diseases during the SARS-CoV-2 pandemic

A Global Effort to Define the Human Genetics of Protective Immunity to SARS-CoV-2 Infection

Angiotensin‐converting enzyme II expression and its implication in the association between COVID‐19 and allergic rhinitis

Dexamethasone, pro‐resolving lipid mediators and resolution of inflammation in COVID‐19

The role of circulating eosinophils on COVID‐19 mortality varies by race/ethnicity

Elastase and Exacerbation of Neutrophil Innate Immunity are Involved in Multi‐Visceral Manifestations of COVID‐19￼￼

Skin tests in urticaria/angioedema and flushing to Pfizer‐BioNTech SARS‐CoV‐2 vaccine: limits of intradermal testing

Vaccines and allergic reactions: the past, the current COVID‐19 pandemic, and future perspectives

Real‐life impact of COVID‐19 pandemic lockdown on the management of pediatric and adult asthma: a survey by the EAACI Asthma Section

Detection of SARS‐CoV‐2 Specific Memory B cells to Delineate Long‐Term COVID‐19 Immunity

Pros and Cons for the role of air pollution on COVID-19 Development

Differentiation of COVID-19 signs and symptoms from allergic rhinitis and common cold – an ARIA- EAACI – GA2LEN consensus

Allergenic components of the mRNA‐1273 vaccine for COVID‐19: possible involvement of polyethylene glycol and IgG‐mediated complement activation

COVID-19 Pandemic and allergen immunotherapy – an EAACI survey

Impact of anxiety, stress and depression related to COVID-19 pandemic on the course of hereditary angioedema with C1 inhibitor deficiency

Childhood asthma outcomes during the COVID-19 pandemic: Findings from the PeARL multi-national cohort￼

Management of patients with atopic dermatitis undergoing systemic therapy during COVID‐19 pandemic in Italy: data from the DA‐COVID‐19 registry

Enzymatic activity of ACE2 regulates type 2 airway inflammation in mice

EAACI statement on the diagnosis, management and prevention of severe allergic reactions to COVID‐19 vaccines

Association of endopeptidases, involved in SARS‐CoV‐2 infection, with microbial aggravation in sputum of severe asthma

Genetic Predisposition to allergic diseases is inversely associated to risk of COVID-19

ARIA‐EAACI statement on severe allergic reactions to COVID‐19 vaccines – an EAACI‐ARIA position paper

SARS-COV-2 Candidate vaccines – composition, mechanisms of action and stages of clinical development ￼

Allergic reactions to the first COVID‐19 vaccine: a potential role of polyethylene glycol?￼

Multidisciplinary consensus on sputum induction biosafety during the COVID-19 pandemic

The global impact of the COVID-19 pandemic on the management and course of chronic urticaria

Association between asthma and clinical mortality/morbidity in COVID‐19 patients using clinical epidemiologic data from Korean Disease Control & Prevention

Distinct expression of SARS- CoV-2 receptor ACE2 correlates with endotypes of rhinosinusitis with nasal polyps

Risk factors for severe and critically ill COVID-19 patients: A review

Immunological imprint of COVID-19 on human peripheral blood leukocyte populations

Is there a role for childhood vaccination against COVID-19?￼

Management of patients with chronic rhinosinusitis during the COVID‐19 pandemic – An EAACI Position Paper

Antibody dynamics to SARS‐CoV‐2 in asymptomatic COVID‐19 infections

Regional differences in ACE2 expression in the sinonasal mucosa of adult Chinese patients with chronic rhinosinusitis

Characterization of asthma and risk factors for delayed SARS‐CoV‐2 clearance in adult COVID‐19 inpatients in Daegu

Accuracy of serological testing for SARS‐CoV‐2 antibodies: first results of a large mixed‐method evaluation study

Small droplet emission in exhaled breath during different breathing manoeuvres: Implications for clinical lung function testing during COVID‐19

Asthma control, self‐management and healthcare access during the COVID‐19 epidemic in Beijing

The younger the milder clinical course of COVID-19 – even in infants? ￼

The potential threat of multisystem inflammatory syndrome in children during the COVID-19 pandemic

Thirty‐six COVID‐19 cases preventively vaccinated with mumps‐measles‐rubella vaccine: all mild course

Atopic status protects from severe complications of COVID‐19

Severe asthma in adults does not significantly affect the outcome of COVID‐19 disease: results from the Italian Severe Asthma Registry

Cabbage and fermented vegetables: from death rate heterogeneity in countries to candidates for mitigation strategies of severe COVID‐19

Shielding against SARS-CoV-2 infections is not justified in children with severe asthma ￼

Cross‐sectional pilot study exploring the feasibility of a rapid SARS‐CoV‐2 immunization test in health and nonhealthcare workers

Delayed virus‐specific antibody responses associate with COVID‐19 mortality

Blood myeloperoxidase‐DNA, a biomarker of early response to SARS‐CoV‐2 infection?

COVID‐19 in Severe Asthma Network in Italy (SANI) patients: Clinical features, impact of comorbidities and treatments

Antibodies in serum of convalescent patients following mild COVID‐19 do not always prevent virus‐receptor binding

Bacillus Calmette‐Guérin vaccination and socioeconomic variables vs COVID‐19 global features: Clearing up a controversial issue

SARS‐CoV‐2 receptor ACE2 protein expression in serum is significantly associated with age

A male infant with COVID-19 in the context of ARPC1B Deficiency

Genome-wide CRISPR screen reveals host genes that regulate SARS-CoV-2 infection

Postnatal SARS‐CoV‐2 Infection and Immunological Reaction: A Prospective Family Cohort Study

First antibody trial launched in COVID-19 patients

African American children are at higher risk for COVID‐19 infection

SARS-CoV-2 receptor ACE2 is an interferon-stimulated gene in human airway epithelial cells and is detected in specific cell subsets across tissues

APOE e4 Genotype Predicts Severe COVID-19 in the UK Biobank Community Cohort

Symptoms and immunoglobulin development in hospital staff exposed to a SARS‐CoV‐2 outbreak

The first, holistic immunological model of COVID‐19: Implications for prevention, diagnosis, and public health measures

Biologics increase the risk of SARS-CoV-2 infection and hospitalization, but not ICU admission and death: real-life data from a large cohort during RED-ZONE declaration

SARS‐CoV‐2 infection in children – Understanding the immune responses and controlling the pandemic

Association of Respiratory Allergy, Asthma and Expression of the SARS-CoV-2 Receptor, ACE2

Successful containment of COVID‐19 outbreak in a large maternity and perinatal center while continuing clinical service

Two X‐linked agammaglobulinemia patients develop pneumonia as COVID‐19 manifestation but recover

Managing childhood allergies and immunodeficiencies during respiratory virus epidemics – the 2020 COVID‐19 pandemic – A statement from the EAACI-Section on Pediatrics

COVID-19: Pandemic Contingency Planning for the Allergy and Immunology Clinic

World Allergy Organization (WAO): Preparing your office for the COVID-19 Pandemic

DGAKI statement on asthma and COVID-19

Elastase and Exacerbation of Neutrophil Innate Immunity are Involved in Multi‐Visceral Manifestations of COVID‐19

Childhood asthma outcomes during the COVID-19 pandemic: Findings from the PeARL multi-national cohort

SARS-COV-2 Candidate vaccines – composition, mechanisms of action and stages of clinical development

Allergic reactions to the first COVID‐19 vaccine: a potential role of polyethylene glycol?

Is there a role for childhood vaccination against COVID-19?

The younger the milder clinical course of COVID-19 – even in infants?

Shielding against SARS-CoV-2 infections is not justified in children with severe asthma